<DOC>
	<DOCNO>NCT00920959</DOCNO>
	<brief_summary>To demonstrate once-daily dose ADVAIR 100/50 once-daily superior efficacy comparable safety compare FP 100mcg once-daily pediatric subject 4 11 year age asthma .</brief_summary>
	<brief_title>Advair Pediatric Once-Daily</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Outpatients Asthma diagnosis Reversibility Shortacting betaagonist asthma control medication use Lifethreatening asthma Specified asthma medication Chickenpox Drug allergy Respiratory infection Tobacco use Clinical laboratory abnormality Ophthalmologic condition Investigation medication Affiliation investigator site</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>